Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan

Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., Oct. 21, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI ) (“HCTI” or the “Company”), a leader in digital transformation solutions incl

Event · Stock split
Ratio
1-for-20
Reverse split
yes
Effective
Monday, October 26, 2026

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 27, 2026, 9:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$HCTI
Neutral
high confidence
Mentioned
$HCTI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HCTINeutralLow
01

Why it matters

The reverse split is intended to bring the stock back into compliance, which may temporarily boost the price but does not address underlying business performance.

02

Market read

A corporate action aimed at Nasdaq compliance; short‑term price adjustment expected, long‑term impact depends on business fundamentals.

03

What to watch

Potential dilution from future capital raises and the reduced share liquidity could affect long‑term price stability.

Relevance 6/10Novelty 6/10Timing: effective at market open on Oct 26, post‑split trading today

Background

Healthcare Triangle provides digital transformation services to the healthcare and life‑sciences sectors and is currently below Nasdaq's $1 minimum bid price requirement.

Company-level read

Ticker impact

$HCTINeutralHigh confidence
Context

The company filed an 8‑K announcing a 1‑for‑20 reverse stock split to regain Nasdaq $1 minimum price compliance.

Expected impact

potential modest upside as the split lifts the share price above $1, but limited upside due to reduced float

Evidence & confidence

Reverse splits are typically priced in quickly; the market will adjust on the first trading day post‑split.

Market effects

May prompt other low‑price Nasdaq‑listed healthcare tech stocks to consider similar actions to avoid delisting.

Limited to U.S. Nasdaq micro‑cap segment.

Minimal global impact.

Counterpoint

Investors may view the split as a cosmetic fix and could short the stock if fundamentals remain weak.

Key entities

  • Healthcare Triangle, Inc.

    Nasdaq‑listed provider of cloud and data analytics solutions for healthcare.

  • VStock Transfer, LLC

    Transfer agent handling shareholder communications for the split.

Related articles

$HCTIMedAI 8/10

Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026

Healthcare Triangle (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19 million, up 158% year over year, and gross profit of $2.07 million, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition added $6.31 million revenue. Stockholders’ equity rose to $49.1 million from $9.9 million.

$HCTIMed

Healthcare Triangle, Inc.: Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026

Healthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.

$HCTIMedAI 8/10

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Healthcare Triangle (Nasdaq: HCTI) said it signed a non-binding LOI to acquire a 51% stake in CosmoInnovations (CosmoAesthetics Pty Ltd). Proposed consideration is $23.5 million over three years via cash, equity, and performance milestones. The deal would add 27 granted international patents and 61 pending applications, targeting over $50 million cumulative revenue in three years.